Arrowhead Pharmaceuticals, Inc. (ARWR) financial statements (2020 and earlier)

Company profile

Business Address 225 SOUTH LAKE AVENUE
PASADENA, CA 91101
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q1
9/30/2019
Q4
6/30/2019
Q3
3/31/2019
Q2
12/31/2018
Q1
9/30/2018
Q4
6/30/2018
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5022592372182447760
Cash and cash equivalents4612221881621903028
Short-term investments41374957544632
Restricted cash and investments  1    
Receivables11213300
Prepaid expense3332211
Other current assets2312010
Total current assets:5082652452352497962
Noncurrent Assets
Operating lease, right-of-use asset10   
Property, plant and equipment26231713141414
Long-term investments and receivables2644586860 18
Long-term investments2644586860 18
Intangible assets, net (including goodwill)17171718181919
Intangible assets, net (excluding goodwill)17171718181919
Other noncurrent assets0000000
Total noncurrent assets:80859299923351
TOTAL ASSETS:588350337334341112113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities191911119125
Accounts payable12854432
Accrued liabilities4756452
Employee-related liabilities3511241
Deferred revenue5478  
Debt0    00
Deferred rent credit 000000
Contract with customer, liability7691125  
Other liabilities00   00
Other undisclosed current liabilities     01
Total current liabilities:749787102135127
Noncurrent Liabilities
Long-term debt and lease obligation14    22
Long-term debt, excluding current maturities     22
Operating lease, liability14   
Liabilities, other than long-term debt 924313522
Deferred revenue 5  
Contract with customer, liability223033  
Deferred rent credit 422222
Other liabilities     00
Total noncurrent liabilities:14924313544
Total liabilities:881061111331691611
Stockholders' equity
Stockholders' equity attributable to parent50024522620117296102
Common stock0000000
Additional paid in capital922664657652647583579
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(422)(419)(431)(451)(475)(487)(477)
Stockholders' equity attributable to noncontrolling interest(1)(1)(1)(1)(1)(1)(1)
Total stockholders' equity:50024422620117295102
TOTAL LIABILITIES AND EQUITY:588350337334341112113

Income statement (P&L) ($ in millions)

12/31/2019
Q1
9/30/2019
Q4
6/30/2019
Q3
3/31/2019
Q2
12/31/2018
Q1
9/30/2018
Q4
6/30/2018
Q3
Gross profit:2943434835111
Operating expenses(34)(34)(24)(26)(24)(22)(17)
Operating income (loss):(5)10192211(11)(16)
Nonoperating income2222100
Investment income, nonoperating(0)(0)  0  
Income (loss) from continuing operations before income taxes:(3)12202412(11)(16)
Other undisclosed loss from continuing operations (0)   (0) 
Net income (loss) available to common stockholders, diluted:(3)12202412(11)(16)

Comprehensive Income ($ in millions)

12/31/2019
Q1
9/30/2019
Q4
6/30/2019
Q3
3/31/2019
Q2
12/31/2018
Q1
9/30/2018
Q4
6/30/2018
Q3
Net income (loss):(3)12202412(11)(16)
Comprehensive income (loss):(3)12202412(11)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)(0)(0)(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(2)11202412(11)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: